Wednesday, June 25, 2025 | 01:49 PM ISTहिंदी में पढें
Business Standard
Notification Icon
userprofile IconSearch

Letter to BS: Hope Oxford Covid-19 vaccine put an end to our misery

There is something to rejoice as Serum Institute of India has entered into a manufacturing partnership with AstraZeneca once the vaccine trial is successful

covid-19, vaccine, coronavirus
premium

Business Standard
The good news that early-stage clinical trials of the Oxford University Covid-19 vaccine candidate (AZD1222), licensed by AstraZeneca pharmaceuticals, is safe and in­duces an immune response truly gives the world a glimmer of hope at a time when it is facing one of the deadliest pandemic in recent times. Though more tests have to be done before it is made available for public, there is hope for mankind even as the pandemic has already claimed more than six lakh lives and infected millions of people around the globe. Many other nations, including India, are also on the path of developing